Novogen and CanTx Confirm Trx-1 Potency in Ovarian Stem Cell Model

News   Jun 19, 2014

 
Novogen and CanTx Confirm Trx-1 Potency in Ovarian Stem Cell Model
 
 
 

RELATED ARTICLES

Lonza Expands Encapsulation and HPAPI Capabilities in North America

News

Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.

READ MORE

Cancer Pioneer Employs Physics to Approach Cancer

News

In the cover article of Oncotarget, February 20, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.

READ MORE

Novel Scaffolds to Grow Muscle Developed

News

RMIT biomedical engineers have successfully produced a 3D material that mimics nature to transform cells into muscle.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE